Corvus Pharmaceuticals In... (CRVS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
5.00
0.27 (5.71%)
At close: Jan 17, 2025, 3:59 PM
5.01
0.10%
After-hours Jan 17, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Cash & Equivalents | 12.62M | 13.16M | 63.46M | 16.45M | 5.15M | 114.60M | 90.06M | 134.90M | 4.11M | 12.52M |
Short-Term Investments | 14.53M | 29.14M | 5.99M | 27.80M | 72.83M | 75.40M | 44.95M | 129.85M | 90.28M | n/a |
Long-Term Investments | 16.12M | 21.88M | 34.27M | 37.23M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 89.00K | 1.84M | 2.55M | 2.40M | 3.34M | 1.46M | 2.05M | 2.01M | 951.00K | n/a |
Receivables | 63.00K | 633.00K | 539.00K | 86.00K | 329.00K | 337.00K | 132.00K | 365.00K | 347.00K | n/a |
Inventory | n/a | -735.00K | -667.00K | -492.00K | -815.00K | -602.00K | -852.00K | -1.14M | 722.00K | n/a |
Other Current Assets | 744.00K | 728.00K | 1.32M | 991.00K | 1.03M | 655.00K | 1.05M | 772.00K | 930.00K | 12.00K |
Total Current Assets | 27.96M | 42.30M | 69.45M | 44.26M | 77.98M | 114.60M | 90.06M | 134.90M | 95.66M | 12.53M |
Property-Plant & Equipment | 1.39M | 2.22M | 3.19M | 1.65M | 2.33M | 2.18M | 2.67M | 3.25M | 1.84M | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 17.60M | 25.94M | 40.00M | 41.27M | 5.66M | 3.63M | 4.72M | 5.25M | 2.80M | n/a |
Total Assets | 45.55M | 68.24M | 109.45M | 85.53M | 83.65M | 118.23M | 94.78M | 140.15M | 98.46M | 12.53M |
Account Payables | 1.52M | 1.98M | 1.56M | 3.47M | 2.45M | 2.00M | 3.45M | 1.90M | 1.57M | 57.00K |
Deferred Revenue | n/a | n/a | 6.96M | n/a | n/a | n/a | n/a | n/a | 223.00K | -2.58M |
Short-Term Debt | 1.37M | 1.23M | 1.05M | 1.08M | 878.00K | n/a | n/a | n/a | n/a | 2.60M |
Other Current Liabilities | 3.97M | 7.55M | 7.08M | 7.60M | 6.90M | 5.03M | 5.51M | 4.04M | 1.27M | 17.00K |
Total Current Liabilities | 6.87M | 12.13M | 12.29M | 13.38M | 12.54M | 7.90M | 9.94M | 7.35M | 3.07M | 2.67M |
Long-Term Debt | n/a | 2.75M | 5.20M | 2.46M | 4.62M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | -1.37M | -2.60M | -1.23M | -2.31M | 869.00K | 971.00K | 1.41M | 126.49M | 10.01M |
Total Long-Term Liabilities | n/a | 1.37M | 2.60M | 1.23M | 2.31M | 869.00K | 971.00K | 1.41M | 126.49M | 10.01M |
Total Liabilities | 6.87M | 12.13M | 12.29M | 13.38M | 12.54M | 7.90M | 9.94M | 7.35M | 129.56M | 12.69M |
Total Debt | 1.37M | 2.60M | 3.65M | 2.31M | 3.19M | n/a | n/a | n/a | n/a | 2.60M |
Common Stock | 5.00K | 5.00K | 5.00K | 3.00K | 3.00K | 3.00K | 2.00K | 2.00K | n/a | n/a |
Retained Earnings | -334.72M | -307.69M | -266.38M | -223.14M | -217.15M | -170.47M | -123.53M | -67.87M | -31.50M | -161.00K |
Comprehensive Income | -967.00K | -563.00K | 1.87M | 4.00K | 29.00K | -34.00K | -41.00K | -39.00K | -45.00K | n/a |
Shareholders Equity | 38.68M | 56.12M | 97.16M | 72.15M | 71.11M | 110.34M | 84.83M | 132.80M | -31.10M | -159.00K |
Total Investments | 30.65M | 51.02M | 40.26M | 65.03M | 72.83M | 75.40M | 44.95M | 129.85M | 90.28M | n/a |